Opaleye Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Opaleye Management’s Portfolio VIRX Stock Details VIRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell
2021 Q3	$2.07M	Buy
2021 Q2	$2.92M	Buy
2021 Q1	$958K	Buy
2017 Q3	–	Sell
2017 Q2	$1.03M	Sell
2017 Q1	$2.25M	Buy